Scientific Vita
Con­tact
Info

Prof. Dr.

Klaus Schulze-Osthoff

Project: A06

Academic Education and Scientific Degrees
1994
Postdoctoral thesis ('Habilitation') in Exp. Immunology, University of Heidelberg. Mentor: Prof. H. zur Hausen
1992-1995
Senior Scientist, German Cancer Research Center (DKFZ), Heidelberg
1990-1992
Postdoctoral researcher, Laboratory of Molecular Biology (Prof. W. Fiers), University of Ghent, Belgium
1986-1990
Scientific assistant, Institute for Experimental Dermatology, University of Münster
1988
PhD thesis with Prof. C. Sorg, Institute of Experimental Dermatology, University of Münster
1979-1988
Studies of Biology and Medicine, University of Münster

Professional Career
Since 2008
Full Professor (W3) and Head of the Dept. of Molecular Medicine, Interfaculty Institute for Biochemistry, University of Tübingen
2001-2008
Full Professor (C4) and founding Director of the Institute of Molecular Medicine, University of Düsseldorf
1999-2001
Professor (C3), Dept. of Immunology and Cell Biology, University of Münster
1997-1998
Professor (C3), Dept. Internal Medicine I, University of Tübingen
1995-1997
Assistant Professor (C2), Institute for Biochemistry and Molecular Biology (Prof. P.A. Baeuerle), University of Freiburg
Address
Interfaculty Institute of Biochemistry
Department of Molecular Medicine
Eberhard Karls University Tübingen
Hoppe-Seyler-Str. 4, 72070 Tübingen

German Cancer Consortium (DKTK)
German Cancer Rese
Phone
+49/7071/297 3399
eMail
kso@uni-tuebingen.de
Awards and Appointments
1997-2009
Offers for professorships at Universities of Halle (C4, 1997), Bonn (C4, 2000), and Dortmund (W3 and Directorship of Leibniz-Institute IfADo, 2009); all declined
2008
Innovation Award for German University Medicine, Berlin, Germany
1995
International Award 'Skin and Environment’, Grünenthal AG, Germany
1990-1995
Fellowship Award of the German Ministry for Education and Research

Others
Since 2013
Fellow of the German Cancer Research Center, DKFZ
Since 2012
Scientific Advisory Board Member, Comprehensive Cancer Center Düsseldorf
Since 2010
Coordinator of the German Consortium for Translational Cancer Research (DKTK), partner site Tübingen
Since 2009
Member of the Research Committee of the Medical Faculty, University of Tübingen
Since 2008
Board Member of the Comprehensive Cancer Center Tübingen
Since 2001
Board Member of Biocheck GmbH, Münster, Germany
2011-2013
Spokesperson of the Collaborative Research Center 773 “Therapy resistance of solid tumors”
2009-2013
Scientific director, Comprehensive Cancer Center Tübingen
2008-2012
Member of the scientific committee 'Emerging and Newly Identified Health Risks' (SCENIHR) of the European Commission, Brussels

Patents
Patent family “Apoptosis Inhibitors” US020070243577, EP199500090973, EP000000705278.
Peptide(s) corresp. to CD4 receptor epitope(s) used for treatment of AIDS; US2007207160-A1.
Patent family “Apoptosis Biomarkers”, EP000001394184, EP000001157221, EP000001301786, WO002002008752.
Peptide(s) containing epitope(s) characteristic of peptide(s) formed during apoptosis; US2007243577-A1.
Method for the detection of DNA damage. DPMA 20122145192300DE, WO 2014090762 A1
Senescence tracers: EP2890981-A1.